{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T09:30:44Z","timestamp":1790501444090,"version":"4.1.0"},"reference-count":27,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,1,1]]},"abstract":"<jats:p>Type Vicenza variant of von Willebrand disease (VWD) is characterized by a low plasma von Willebrand factor (VWF) level and supranormal VWF multimers. Two candidate mutations, G2470A and G3864A at exons 17 and 27, respectively, of the VWF gene were recently reported to be present in this disorder. Four additional families, originating from northeast Italy, with both mutations of type Vicenza VWD are now described. Like the original type Vicenza subjects, they showed a mild bleeding tendency and a significant decrease in plasma VWF antigen level and ristocetin cofactor activity but normal platelet VWF content. Unlike the original patients, ristocetin-induced platelet aggregation was found to be normal. Larger than normal VWF multimers were also demonstrated in the plasma. Desmopressin (DDAVP) administration increased factor VIII (FVIII) and VWF plasma levels, with the appearance of even larger multimers. However, these forms, and all VWF oligomers, disappeared rapidly from the circulation. The half-life of VWF antigen release and of elimination was significantly shorter than that in healthy counterparts, so that at 4 hours after DDAVP administration, VWF antigen levels were close to baseline. Similar behavior was demonstrated by VWF ristocetin cofactor activity and FVIII. According to these findings, it is presumed that the low plasma VWF levels of type Vicenza VWD are mainly attributed to reduced survival of the VWF molecule, which, on the other hand, is normally synthesized. In addition, because normal VWF-platelet GPIb interaction was observed before or after DDAVP administration, it is proposed that type Vicenza VWD not be considered a 2M subtype.<\/jats:p>","DOI":"10.1182\/blood.v99.1.180","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T12:47:58Z","timestamp":1027774078000},"page":"180-184","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":122,"title":["Reduced von Willebrand factor survival in type Vicenza von Willebrand disease"],"prefix":"10.1182","volume":"99","author":[{"given":"Alessandra","family":"Casonato","sequence":"first","affiliation":[{"name":"From the Department of Medical and Surgical Sciences, Second Chair of Internal Medicine, and the Department of Pharmacology and Anesthesiology, University of Padua Medical School, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Pontara","sequence":"additional","affiliation":[{"name":"From the Department of Medical and Surgical Sciences, Second Chair of Internal Medicine, and the Department of Pharmacology and Anesthesiology, University of Padua Medical School, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Sartorello","sequence":"additional","affiliation":[{"name":"From the Department of Medical and Surgical Sciences, Second Chair of Internal Medicine, and the Department of Pharmacology and Anesthesiology, University of Padua Medical School, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Cattini","sequence":"additional","affiliation":[{"name":"From the Department of Medical and Surgical Sciences, Second Chair of Internal Medicine, and the Department of Pharmacology and Anesthesiology, University of Padua Medical School, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Sartori","sequence":"additional","affiliation":[{"name":"From the Department of Medical and Surgical Sciences, Second Chair of Internal Medicine, and the Department of Pharmacology and Anesthesiology, University of Padua Medical School, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Padrini","sequence":"additional","affiliation":[{"name":"From the Department of Medical and Surgical Sciences, Second Chair of Internal Medicine, and the Department of Pharmacology and Anesthesiology, University of Padua Medical School, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Girolami","sequence":"additional","affiliation":[{"name":"From the Department of Medical and Surgical Sciences, Second Chair of Internal Medicine, and the Department of Pharmacology and Anesthesiology, University of Padua Medical School, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021219380568500_B1","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood.V70.4.895.895","article-title":"Von Willebrand factor and von Willebrand disease.","volume":"70","author":"Ruggeri","year":"1987","journal-title":"Blood."},{"key":"2020021219380568500_B2","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease.","volume":"71","author":"Sadler","year":"1994","journal-title":"Thromb Haemost."},{"key":"2020021219380568500_B3","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198005083021902","article-title":"Heightened interaction between platelets and factor VIII\/von Willebrand factor in a new subtype of von Willebrand disease.","volume":"302","author":"Ruggeri","year":"1980","journal-title":"N Engl J Med."},{"key":"2020021219380568500_B4","doi-asserted-by":"crossref","first-page":"9846","DOI":"10.1073\/pnas.89.20.9846","article-title":"von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib.","volume":"89","author":"Rabinowitz","year":"1992","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021219380568500_B5","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1172\/JCI109795","article-title":"Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII\/von Willebrand factor in plasma and platelets.","volume":"65","author":"Ruggeri","year":"1980","journal-title":"J Clin Invest."},{"key":"2020021219380568500_B6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1182\/blood.V71.1.65.65","article-title":"von Willebrand disease \u201cVicenza\u201d with larger-than normal (supranormal) von Willebrand factor multimers.","volume":"71","author":"Mannucci","year":"1988","journal-title":"Blood."},{"key":"2020021219380568500_B7","first-page":"136","article-title":"Von Willebrand disease type 2M \u201cVicenza\u201d in Italian and German patients: identification of the first candidate mutation (G3864A; R1205H) in 8 families.","volume":"82","author":"Schneppenheim","year":"2000","journal-title":"Thromb Haemost."},{"key":"2020021219380568500_B8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0049-3848(97)00104-7","article-title":"New families with von Willebrand disease type 2M (Vicenza).","volume":"87","author":"Zieger","year":"1997","journal-title":"Thromb Res."},{"key":"2020021219380568500_B9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/blood.V58.2.387.387","article-title":"Effect of multimeric structure of the factor VIII\/von Willebrand factor protein on binding to platelets.","volume":"58","author":"Gralnick","year":"1981","journal-title":"Blood."},{"key":"2020021219380568500_B10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0049-3848(92)90242-3","article-title":"In vivo experiments indicate that relatively high platelet deposition in von Willebrand disease \u201cVicenza\u201d is caused by normal platelet-VWF levels rather than by high VWF-multimers in plasma.","volume":"65","author":"d'Alessio","year":"1992","journal-title":"Thromb Res."},{"key":"2020021219380568500_B11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-0038-1642670","article-title":"Molecular mechanism and classification of von Willebrand factor disease.","volume":"74","author":"Sadler","year":"1995","journal-title":"Thromb Haemost."},{"key":"2020021219380568500_B12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1055\/s-0038-1651575","article-title":"The genetic defect of type I von Willebrand disease \u201cVicenza\u201d is linked to the von Willebrand factor gene.","volume":"69","author":"Randi","year":"1993","journal-title":"Thromb Haemost."},{"key":"2020021219380568500_B13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1055\/s-0037-1614019","article-title":"An additional unique candidate mutation (G2470A; M740I) in the original families with von Willebrand disease type 2M Vicenza and the G3864A (R1205H) mutation.","volume":"84","author":"Castaman","year":"2000","journal-title":"Thromb Haemost."},{"key":"2020021219380568500_B14","first-page":"97","article-title":"A new variant of von Willebrand's disease (type I Padua): doublet-organized plasma von Willebrand oligomers in the presence of all size multimers.","volume":"26","author":"Casonato","year":"1994","journal-title":"Haematologia."},{"key":"2020021219380568500_B15","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1182\/blood.V74.6.2028.2028","article-title":"A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction and the presence of all von Willebrand factor multimers in plasma.","volume":"74","author":"Casonato","year":"1989","journal-title":"Blood."},{"key":"2020021219380568500_B16","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00001721-199204000-00003","article-title":"Impaired release of tissue plasminogen activator (t-PA) following DDAVP infusion in von Willebrand's disease with low platelet von Willebrand factor content.","volume":"3","author":"Casonato","year":"1992","journal-title":"Blood Coagul Fibrinolysis."},{"key":"2020021219380568500_B17","first-page":"309","article-title":"The evaluation of factor VIII antigen by means of a simple slide test.","volume":"29","author":"Casonato","year":"1985","journal-title":"Am J Clin Pathol."},{"key":"2020021219380568500_B18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2141.1970.tb01615.x","article-title":"A new congenital haemorrhagic condition due to the presence of abnormal factor X (factor X Friuli): study of a large kindred.","volume":"19","author":"Girolami","year":"1970","journal-title":"Br J Haematol."},{"key":"2020021219380568500_B19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0022-2143(97)90147-5","article-title":"Abnormal collagen binding activity of 2A von Willebrand factor: evidence that the defects depends only on the lack of large multimers.","volume":"129","author":"Casonato","year":"1997","journal-title":"J Lab Clin Med."},{"key":"2020021219380568500_B20","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/blood.V59.6.1272.1272","article-title":"Multimeric composition of factor VIII\/von Willebrand factor following administration of DDAVP: implications for pathophysiology and therapy in von Willebrand's disease subtypes.","volume":"59","author":"Ruggeri","year":"1982","journal-title":"Blood."},{"key":"2020021219380568500_B21","volume-title":"Pharmacokinetics.","author":"Gibaldi","year":"1975"},{"key":"2020021219380568500_B22","first-page":"1661","article-title":"Mutations causing dominant type 1 von Willebrand disease with high penetrance [abstract].","volume":"94(suppl 1)","author":"Bodo'","year":"1991","journal-title":"Blood."},{"key":"2020021219380568500_B23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1365-2141.1994.tb04734.x","article-title":"The role of platelet von Willebrand factor in platelet adhesion and thrombus formation: a study of 34 patients with various subtypes of type I von Willebrand disease.","volume":"86","author":"Fressinaud","year":"1994","journal-title":"Br J Haematol."},{"key":"2020021219380568500_B24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ajh.2830450303","article-title":"Von Willebrand's disease: use of collagen binding assay provides potential improvement to laboratory monitoring of desmopressin (DDAVP) therapy.","volume":"45","author":"Favaloro","year":"1994","journal-title":"Am J Haematol."},{"key":"2020021219380568500_B25","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1055\/s-0037-1614616","article-title":"Which assay is the most suitable to investigate von Willebrand factor functional activity?","volume":"81","author":"Casonato","year":"1999","journal-title":"Thromb Haemost."},{"key":"2020021219380568500_B26","first-page":"1207","article-title":"In vitro correction of the abnormal multimeric structure of von Willebrand factor in type IIA von Willebrand's disease: studies with protease inhibitors.","volume":"68","author":"Gralnick","year":"1985","journal-title":"Blood."},{"key":"2020021219380568500_B27","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1073\/pnas.87.16.6306","article-title":"Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor.","volume":"87","author":"Dent","year":"1990","journal-title":"Proc Natl Acad Sci U S A."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/1\/180\/1679775\/h80102000180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/1\/180\/1679775\/h80102000180.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T01:12:57Z","timestamp":1581556377000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/99\/1\/180\/107294\/Reduced-von-Willebrand-factor-survival-in-type"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v99.1.180","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1,1]]}}}